Menu
05/10/2005
Breast cancer drug to be fast-tracked
Health Secretary Patricia Hewitt has announced that all breast cancer sufferers will have the opportunity to be treated with the drug, Herceptin.
From Wednesday, all women diagnosed with early stage breast cancer will have the opportunity to be treated with the drug, which is currently only used on patients with advanced breast cancer or those who are terminally ill.
Ms Hewitt said that Herceptin could save around 1,000 lives per year at an annual cost of around £100 million.
The announcement comes two days after former nurse, Barbara Clark, won her battle to receive Herceptin treatment on the NHS.
She had been diagnosed with cancer earlier this year, but could not receive the treatment because the disease was not terminal.
The National Cancer Director Professor Mike Richards is meeting the medical directors of the NHS Cancer Networks on Thursday to discuss the introduction of the new testing service.
Last month, pharmaceutical company, Roche, which manufactures Herceptin, said that an application for a licence for the drug would be made to the European Medicines MEA in February 2006. They anticipated that a decision would be made by July 2006 at the earliest.
Ms Hewitt said that as soon as the license was received the drug would be fast-tracked throughout the NHS. She said: “Herceptin has the potential to save many women's lives and I want to see it in widespread use on the NHS. Today, I am asking Professor Mike Richards to ensure that the facilities are put in place to enable women who require it to be tested. I want the licence for Herceptin to be granted as quickly as possible, without compromising people's safety, and to be available within weeks of the licence being given.
“I share the huge frustration of many women about the delays in getting Herceptin licensed. I am determined to take action, and this represents a major step forward in our fight against cancer.”
(KMcA/SP)
From Wednesday, all women diagnosed with early stage breast cancer will have the opportunity to be treated with the drug, which is currently only used on patients with advanced breast cancer or those who are terminally ill.
Ms Hewitt said that Herceptin could save around 1,000 lives per year at an annual cost of around £100 million.
The announcement comes two days after former nurse, Barbara Clark, won her battle to receive Herceptin treatment on the NHS.
She had been diagnosed with cancer earlier this year, but could not receive the treatment because the disease was not terminal.
The National Cancer Director Professor Mike Richards is meeting the medical directors of the NHS Cancer Networks on Thursday to discuss the introduction of the new testing service.
Last month, pharmaceutical company, Roche, which manufactures Herceptin, said that an application for a licence for the drug would be made to the European Medicines MEA in February 2006. They anticipated that a decision would be made by July 2006 at the earliest.
Ms Hewitt said that as soon as the license was received the drug would be fast-tracked throughout the NHS. She said: “Herceptin has the potential to save many women's lives and I want to see it in widespread use on the NHS. Today, I am asking Professor Mike Richards to ensure that the facilities are put in place to enable women who require it to be tested. I want the licence for Herceptin to be granted as quickly as possible, without compromising people's safety, and to be available within weeks of the licence being given.
“I share the huge frustration of many women about the delays in getting Herceptin licensed. I am determined to take action, and this represents a major step forward in our fight against cancer.”
(KMcA/SP)
Related UK National News Stories
Click here for the latest headlines.
09 June 2006
Herceptin approved for early breast cancer use on NHS
Breast cancer drug Herceptin has been approved for the treatment of early stage breast cancer on the NHS by the National Institute for Health and Clinical Excellence. Herceptin is effective on the HER2 positive form of breast cancer, which forms around 20% of all breast cancer cases.
Herceptin approved for early breast cancer use on NHS
Breast cancer drug Herceptin has been approved for the treatment of early stage breast cancer on the NHS by the National Institute for Health and Clinical Excellence. Herceptin is effective on the HER2 positive form of breast cancer, which forms around 20% of all breast cancer cases.
25 March 2014
Cancer Research UK Raises Over £8m In Six Days
Cancer Research UK has raised over £8 million in donations in just six days thanks to the #nomakeupselfie trend. The #nomakeupselfie trend isn't something Cancer Research UK started.
Cancer Research UK Raises Over £8m In Six Days
Cancer Research UK has raised over £8 million in donations in just six days thanks to the #nomakeupselfie trend. The #nomakeupselfie trend isn't something Cancer Research UK started.
08 August 2011
Cancer Survivors 'Should Exercise', Charity Claims
More than a million cancer survivors could be putting themselves at risk of long-term health problems because they are not physically active enough, a report by Macmillan Cancer Support has claimed. The charity's report, Move More, said that of the two million cancer survivors in the UK, around 1.
Cancer Survivors 'Should Exercise', Charity Claims
More than a million cancer survivors could be putting themselves at risk of long-term health problems because they are not physically active enough, a report by Macmillan Cancer Support has claimed. The charity's report, Move More, said that of the two million cancer survivors in the UK, around 1.
17 October 2005
Breast cancer can cost ‘thousands’
Breast cancer can cost sufferers thousands of pounds, a survey by a leading cancer charity has revealed. Macmillan Cancer Relief surveyed 50 cancer patients and found that, on average, they spent almost £2,000 on extra costs during their treatment.
Breast cancer can cost ‘thousands’
Breast cancer can cost sufferers thousands of pounds, a survey by a leading cancer charity has revealed. Macmillan Cancer Relief surveyed 50 cancer patients and found that, on average, they spent almost £2,000 on extra costs during their treatment.
17 June 2005
New drug raises hope of cancer treatment
A prototype cancer drug, which could help fight a range of cancers, has shown “promising results” in clinical trials. Scientists from the Institute of Cancer Research found that the 17AAG drug selectively and potently blocked the growth of a wide range of common cancer cells.
New drug raises hope of cancer treatment
A prototype cancer drug, which could help fight a range of cancers, has shown “promising results” in clinical trials. Scientists from the Institute of Cancer Research found that the 17AAG drug selectively and potently blocked the growth of a wide range of common cancer cells.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
